TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
BWT Pharma & Biotech AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
484,991
|
332,340
|
203,082 |
Financial expenses |
7
|
45
|
42 |
Earnings before taxes |
77,867
|
48,243
|
24,396 |
EBITDA |
76,231
|
48,586
|
24,872 |
Total assets |
355,614
|
202,543
|
142,995 |
Current assets |
354,097
|
201,045
|
141,329 |
Current liabilities |
258,862
|
139,065
|
84,773 |
Equity capital |
94,787
|
53,218
|
35,249 |
- share capital |
500
![]() |
500
![]() |
500 |
Employees (average) |
48
|
42
|
37 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
26.7%
|
26.3%
|
24.7% |
Turnover per employee |
10,104
|
7,913
|
5,489 |
Profit as a percentage of turnover |
16.1%
|
14.5%
|
12.0% |
Return on assets (ROA) |
21.9%
|
23.8%
|
17.1% |
Current ratio |
136.8%
|
144.6%
|
166.7% |
Return on equity (ROE) |
82.1%
|
90.7%
|
69.2% |
Change turnover |
152,651
|
129,258
|
-697 |
Change turnover % |
46%
|
64%
|
0% |
Chg. No. of employees |
6
|
5
|
9 |
Chg. No. of employees % |
14%
![]() |
14%
|
32% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.